Huakang
8622.HKHuakang Biomedical Holdings Company Limited Price (8622.HK)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
415,962,411
(2.7984)%Revenue and Profitability
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 19,456,000 | 25,410,000 | 26,541,000 | 28,677,000 | 25,471,000 | 21,967,000 | 26,127,000 | 25,330,000 | 24,629,000 |
| Net Income | 7,934,000 | 8,426,000 | -1,952,000 | -459,000 | -284,000 | -11,627,000 | -4,220,000 | -3,075,000 | -5,782,000 |
| FCF USD | 1,111,000 | 8,612,000 | -2,774,000 | -1,900,000 | -5,598,000 | -6,005,000 | -4,709,000 | 475,000 | -1,550,000 |
| OCF USD | 5,455,000 | 11,255,000 | 2,699,000 | 951,000 | -3,390,000 | -3,924,000 | -2,378,000 | 1,286,000 | -48,000 |
Financial Health - DEBT
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| YTPD | 0.00 | 0.04 | 0.00 | 0.00 | 0.66 | -0.11 | -0.17 | -0.02 | -0.20 |
| D/E | 0.10 | 0.04 | 0.00 | 0.00 | 0.02 | 0.04 | 0.03 | 0.01 | 0.10 |
| CA/CL | 1.88 | 2.36 | 3.32 | 5.82 | 8.80 | 6.37 | 6.21 | 5.46 | 4.08 |
| TA/TL | 2.35 | 2.83 | 4.39 | 6.72 | 9.81 | 6.71 | 7.17 | 6.72 | 4.57 |
| Total Debt | 1,550,000 | 950,000 | 110,000 | 0 | 1,612,000 | 2,642,000 | 1,684,000 | 469,000 | 5,136,000 |
Management Performance
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| ROIC | 51.27% | 37.88% | -4.06% | -1.35% | -0.28% | -13.78% | -6.90% | -5.26% | -11.54% |
| ROE | 50.29% | 34.82% | -5.22% | -0.65% | -0.40% | -18.80% | -7.31% | -5.44% | -11.33% |
| ROA | 0.00% | 26.55% | -0.51% | 1.49% | 0.84% | -15.64% | -5.82% | -4.53% | -8.85% |
| NM % | 40.78% | 33.16% | -7.35% | -1.60% | -1.11% | -52.93% | -16.15% | -12.14% | -23.48% |
| FCF / R% | 0.00% | 33.89% | -10.45% | -6.63% | -21.98% | -27.34% | -18.02% | 1.88% | -6.29% |
| FCF / NI% | 12.07% | 86.60% | 1,123.08% | -152.98% | -850.76% | 52.81% | 120.65% | -15.80% | 26.81% |
| Operating Margin (OM) | 0.00 | 0.82 | 0.71 | 0.64 | 0.62 | 0.29 | 0.09 | -0.12 | -0.26 |
Per Share
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| EPS | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | -0.03 | -0.01 | -0.01 | -0.01 |
| SPS | 0.05 | 0.06 | 0.07 | 0.09 | 0.06 | 0.05 | 0.07 | 0.06 | 0.06 |
| OCPS | 0.01 | 0.03 | 0.01 | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| FCPS | 0.00 | 0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | 0.00 | 0.00 |
| BVPS | 0.04 | 0.06 | 0.09 | 0.23 | 0.18 | 0.15 | 0.14 | 0.14 | 0.12 |
Per Share - CAGR
| Year | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|---|---|
| CAGR-EPS | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | -0.03 | -0.01 | -0.01 | -0.01 |
| CAGR-SPS | 0.05 | 0.06 | 0.07 | 0.09 | 0.06 | 0.05 | 0.07 | 0.06 | 0.06 |
| CAGR-OCPS | 0.01 | 0.03 | 0.01 | 0.00 | -0.01 | -0.01 | -0.01 | 0.00 | 0.00 |
| CAGR-FCPS | 0.00 | 0.02 | -0.01 | -0.01 | -0.01 | -0.02 | -0.01 | 0.00 | 0.00 |
| CAGR-BVPS | 0.04 | 0.06 | 0.09 | 0.23 | 0.18 | 0.15 | 0.14 | 0.14 | 0.12 |